U.S. markets closed

Willow Biosciences Inc. (CANSF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.0600+0.1342 (+14.50%)
At close: 3:59PM EDT

Willow Biosciences Inc.

202, 1201-5th Street SW
Calgary, AB T2R 0Y6
403 910 5140

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Trevor Anthony PetersPres, CEO & Director275.19kN/A1977
Mr. Travis DoupeChief Financial Officer242.33kN/A1972
Dr. Chris SavileChief Operations Officer354.17kN/AN/A
Mr. Troy T. TalkkariVP of Corp. Devel.172.51kN/AN/A
Dr. Mathias Maximilian SchuetzVP of Plant Science144.99kN/AN/A
Mr. Christopher SpeedSr. VP of Sales & MarketingN/AN/AN/A
Mr. Sanjib GillCorp. Sec.N/AN/A1977
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. is headquartered in Calgary, Canada.

Corporate Governance

Willow Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.